JANUARY 1–JUNE 30, 2014 (compared with same period a year ago) · Net sales rose 8% (10% excluding exchange rate effects and divestments) to SEK 50,063m (46,451) · Organic sales growth, which excludes exchange rate effects, acquisitions and divestments, was 3% (4% including Vinda’s organic sales growth) · Operating profit excluding items affecting comparability rose 21% (21% excluding exchange rate effects and divestments) to SEK 5,564m (4,593) · The operating margin excluding items affecting comparability was 11.1% (9.9%) · Profit before tax, excluding items affecting comparability, rose 24% (24% excluding exchange rate effects and divestments) to SEK 5,081m (4,087) · Items affecting comparability totaled SEK -405m (-791) · Earnings per share were SEK 4.66 (3.22) · Cash flow from current operations was SEK 2,078m (2,113) · Recalculations have been made for previous periods on account of new and amended IFRSs and rules governing consolidated financial statements and joint arrangements (see note 6) (Table included in attached pdf) CEO’S COMMENTS We have presented a report for the second quarter of 2014 with continued sales growth, higher earnings and a higher margin compared with the same period a year ago. During the quarter, several innovations and product launches were carried out under the Libero, Libresse, TENA and Tork brands. The efficiency programs in the hygiene and forest products operations continue to deliver cost savings according to plan. Our Tissue and Forest Products business areas showed significant earnings growth. Personal Care was negatively impacted by higher raw material costs and negative exchange rate effects in emerging markets. Consolidated net sales for the second quarter of 2014 grew 12% compared with the same period a year ago. Organic sales growth was 3.3% and pertained to all business areas. Growth was mainly in emerging markets and in the Forest Products business area. Operating profit for the second quarter of 2014, excluding items affecting comparability, rose 29% compared with the same period a year ago. The increase is mainly attributable to a better price/mix, higher volumes, cost savings, the acquisition of the majority shareholding in the Chinese company Vinda, and gains on forest swaps. The operating margin excluding items affecting comparability increased by 1.5 percentage points to 11.4%. Earnings per share grew by 56%. Operating cash flow increased by 28% to SEK 2,060m. As part of our strategy to grow in emerging markets, SCA and Vinda have concluded an agreement under which Vinda will take over SCA’s hygiene operations in China, which will lead to mutual benefits in distribution, sales, innovation, and research and development. SCA’s joint venture in Australia, New Zealand and Fiji – Asaleo Care – has been floated on the Australian Securities Exchange (ASX). SCA’s holding in Asaleo Care after the IPO is approximately 32.5%. For further information, please contact: Johan Karlsson, Vice President Investor Relations, Group Function Communications, +46 8 788 51 30 Boo Ehlin, Vice President Media Relations, Group Function Communications, +46 8 788 51 36 Joséphine Edwall-Björklund, Senior Vice President, Group Function Communications, +46 8 788 52 34 NB SCA discloses the information provided herein pursuant to the Securities Markets Act. This report has been prepared in both Swedish and English versions. In case of variations in the content between the two versions, the Swedish version shall govern. Submitted for publication on July 18, 2014, at 12 noon CET. The Board of Directors and President certify that the interim report gives a true and fair view of the Parent Company’s and Group’s operations, financial position and results of operations, and describes material risks and uncertainties facing the Parent Company and the companies included in the Group.
Interim Report Q2 2014 JANUARY 1–JUNE 30, 2014 (compared
Top 10 Most Recent News Articles
Novo's CagriSema Trials Show Promising Weight Loss
Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...
Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle
IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...
Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake
Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...
Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market
A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...
Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control
Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...
Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives
Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...
Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations
ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...
Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit
A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...
Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
Princess Cruises Launches New Era at Celebration Key
Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...
Continue ReadingTop 5 Most Recently Viewed Articles
Tech Titans Rally: Stock Highlights You Can't Miss Today
Market Overview Recent trading sessions in the U.S. saw mixed results. While the Dow Jones Industrial Average experienced a slight decline, the S&P 500 showed minimal movement. In contrast, the tech-centered Nasdaq showed a modest uptick as many companies presented their earnings. Federal Reserve Updates The Federal Reserve's decision to hold interest rates steady at...
Continue Reading
Investment Growth: Alphabet Stock's Journey Over Two Decades
Understanding the Performance of Alphabet Stock Alphabet (NASDAQ: GOOGL) has consistently demonstrated remarkable growth, outpacing the market by an impressive 9.36% on an annualized basis. This translates to an average annual return of 18.3%, showcasing the company's ability to thrive even amid challenging economic conditions. With a market capitalization soaring to...
Continue Reading
Palantir Technologies Expands with 26 Partnerships in 15 Sectors
Palantir's Remarkable Growth Journey Palantir Technologies Inc (NASDAQ: PLTR) has been making waves in the enterprise software landscape. In merely ten months, the company has successfully formed 26 partnerships across 15 different sectors, a feat that extends its reach well beyond its traditional defense-oriented image. This surge in collaboration indicates its...
Continue Reading
Bitcoin Market Dynamics Shift Amidst Emerging Trends
Bitcoin Market Dynamics Shift Amidst Emerging Trends The financial markets are currently navigating through a phase of cautious optimism, with the leading indices showing modest gains. A notable exception to this trend is Bitcoin, which has recently displayed some volatility. After a significant breakout, Bitcoin encountered a sudden reverse, leading to concerns of a...
Continue Reading
Stifel Financial Corp. Announces Cash Dividends for Investors
Stifel Financial Corporation's Dividend Announcement Stifel Financial Corp. announces a substantial cash dividend for its common stock shareholders, declaring a payout of $0.46 per share. This announcement comes as part of the company's regular financial strategy aimed at rewarding its shareholders. The payment is scheduled for September 16, with shareholders on record as...
Continue Reading